In Vitro Modeling of Skin Barrier Disruption and its Recovery by Ceramide-Based Formulations
Jazyk angličtina Země Spojené státy americké Médium electronic
Typ dokumentu časopisecké články
PubMed
34907505
DOI
10.1208/s12249-021-02154-z
PII: 10.1208/s12249-021-02154-z
Knihovny.cz E-zdroje
- Klíčová slova
- FTIR spectroscopy, ceramides, liposomes, permeation experiment, skin barrier disruption models, stratum corneum lipids, topical treatment,
- MeSH
- ceramidy * MeSH
- epidermis MeSH
- kůže * MeSH
- lipidy MeSH
- permeabilita MeSH
- prasata MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- ceramidy * MeSH
- lipidy MeSH
Disrupted skin barrier, one of the severe attributes of inflammatory skin diseases, is caused by lower content and pathological changes of lipids in the uppermost skin layer-stratum corneum (SC). Restoring skin barrier with native skin lipids, especially ceramides (Cers), appears to be a promising therapy with minimum side effects. For testing the efficiency of these formulations, suitable in vitro models of the skin with disrupted barriers are needed. For the similarity with the human tissue, our models were based on the pig ear skin. Three different ways of skin barrier disruption were tested and compared: tape stripping, lipid extraction with organic solvents, and barrier disruption by sodium lauryl sulfate. The level of barrier disruption was investigated by permeation studies, and parameters of each method were modified to reach significant changes between the non-disrupted skin and our model. Fourier transform infrared (FTIR) spectroscopy was employed to elucidate the changes of the skin permeability on the molecular scale. Further, the potential of the developed models to be restored by skin barrier repairing agents was evaluated by the same techniques. We observed a significant decrease in permeation characteristics through our in vitro models treated with the lipid mixtures compared to the untreated damaged skin, which implied that the skin barrier was substantially restored. Taken together, the results suggest that our in vitro models are suitable for the screening of potential barrier repairing agents.
Zobrazit více v PubMed
Menon GK. New insights into skin structure: scratching the surface. Adv Drug Del Rev. 2002;54(Supplement):S3–17.
Fartasch M. The nature of the epidermal barrier: structural aspects. Adv Drug Deliv Rev. 1996;18(3):273–82.
Menon GK, Cleary GW, Lane ME. The structure and function of the stratum corneum. Int J Pharm. 2012;435(1):3–9. PubMed
Yardley HJ, Summerly R. Lipid composition and metabolism in normal and diseased epidermis. Pharmacol Ther. 1981;13(2):357–83. PubMed
Schurer NY, Elias PM. The biochemistry and function of stratum corneum lipids. In: Elias PM, editor. Advances in Lipid Research. 24: Elsevier; 1991. p. 27–56.
Lampe MA, Burlingame AL, Whitney J, Williams ML, Brown BE, Roitman E, et al. Human stratum corneum lipids: characterization and regional variations. J Lipid Res. 1983;24(2):120–30. PubMed
Feingold KR, Elias PM. Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids. 2014;1841(3):280–94.
Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta, Biomembr. 2006;1758(12):2080–95.
van Smeden J, Janssens M, Gooris GS, Bouwstra JA. The important role of stratum corneum lipids for the cutaneous barrier function. Biochim Biophys Acta, Mol Cell Biol Lipids. 2014;1841(3):295–313.
Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population–based study. J Allergy Clin Immunol. 2013;132(5):1132–8. PubMed
Wolf R, Orion E, Ruocco E, Ruocco V. Abnormal epidermal barrier in the pathogenesis of psoriasis. Clin Dermatol. 2012;30(3):323–8. PubMed
van Smeden J, Bouwstra JA. Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients. Curr Probl Dermatol. 2016;49:8–26. PubMed
Borodzicz S, Rudnicka L, Mirowska-Guzel D, Cudnoch-Jedrzejewska A. The role of epidermal sphingolipids in dermatologic diseases. Lipids Health Dis. 2016;15(1):13. PubMed PMC
Callen J, Chamlin S, Eichenfield LF, Ellis C, Girardi M, Goldfarb M, et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol. 2007;156(2):203–21. PubMed
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1–15. PubMed
Arkwright PD, Motala C, Subramanian H, Spergel J, Schneider LC, Wollenberg A. Management of difficult-to-treat atopic dermatitis. J Allergy Clin Immunol Pract. 2013;1(2):142–51. PubMed
Roekevisch E, Leeflang MMG, Schram ME, Campbell LE, Irwin McLean WH, Kezic S, et al. Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment. Br J Dermatol. 2017;177(6):1745–6. PubMed
Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–32. PubMed PMC
Berkers T, Visscher D, Gooris GS, Bouwstra JA. Topically applied ceramides interact with the stratum corneum lipid matrix in compromised ex vivo skin. Pharm Res. 2018;35(3):48. PubMed PMC
Chamlin SL, Frieden IJ, Fowler A, Williams M, Kao J, Sheu M, et al. Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Arch Dermatol. 2001;137(8):1110–2. PubMed
Elias PM. Lipid abnormalities and lipid-based repair strategies in atopic dermatitis. Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids. 2014;1841(3):323–30.
Draelos ZD. New treatments for restoring impaired epidermal barrier permeability: skin barrier repair creams. Clin Dermatol. 2012;30(3):345–8. PubMed
Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. J Drugs Dermatol. 2009;8(12):1106–11. PubMed
Vovesná A, Zhigunov A, Balouch M, Zbytovská J. Ceramide liposomes for skin barrier recovery: a novel formulation based on natural skin lipids. Int J Pharm. 2021;596:120264. PubMed
Bashir SJ, Chew A-L, Anigbogu A, Dreher F, Maibach HI. Physical and physiological effects of stratum corneum tape stripping. Skin Res Technol. 2001;7(1):40–8. PubMed
Yoshizawa Y, Kitamura K, Kawana S, Maibach HI. Water, salts and skin barrier of normal skin. Skin Res Technol. 2003;9(1):31–3. PubMed
Man M-Q, Feingold KR, Thornfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol. 1996;106(5):1096–101.
Bissonnette R, Maari C, Provost N, Bolduc C, Nigen S, Rougier A, et al. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis. J Cosmet Dermatol. 2010;9(1):16–21. PubMed
Seghers AC, Cai SC, Ho MSL, Giam YC, Tan L, Grönhagen CM, et al. Evaluation of a pseudoceramide moisturizer in patients with mild-to-moderate atopic dermatitis. Dermatol Ther. 2014;4(1):83–92.
Andrews S, Lee JW, Prausnitz M. Recovery of skin barrier after stratum corneum removal by microdermabrasion. AAPS PharmSciTech. 2011;12(4):1393–400. PubMed PMC
Welss T, Basketter DA, Schröder KR. In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol in Vitro. 2004;18(3):231–43. PubMed
Faller C, Bracher M, Dami N, Roguet R. Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics☆☆This study is part of the European project SMT4-CT 97–2174: “Testing and improvement of reconstructed skin kits in order to elaborate European standards”. Toxicol in Vitro. 2002;16(5):557–72. PubMed
Schäfer-Korting M, Mahmoud A, Borgia SL, Brüggener B, Kleuser B, Schreiber S, et al. Reconstructed epidermis and full-thickness skin for absorption testing: influence of the vehicles used on steroid permeation. Altern Lab Anim. 2008;36(4):441–52. PubMed
Sekkat N, Kalia YN, Guy RH. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J Pharm Sci. 2002;91(11):2376–81. PubMed
Barbero AM, Frasch HF. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol in Vitro. 2009;23(1):1–13. PubMed
Danso MO, Berkers T, Mieremet A, Hausil F, Bouwstra JA. An ex vivo human skin model for studying skin barrier repair. Exp Dermatol. 2015;24(1):48–54. PubMed
Abrams K, Harvell JD, Shriner D, Wertz P, Maibach H, Maibach HI, et al. Effect of organic solvents on in vitro human skin water barrier function. J Invest Dermatol. 1993;101(4):609–13. PubMed
Barba C, Alonso C, Martí M, Manich A, Coderch L. Skin barrier modification with organic solvents. Biochim Biophys Acta (BBA)- Biomembr. 2016;1858(8):1935–43.
Wolf R, Parish LC. Effect of soaps and detergents on epidermal barrier function. Clin Dermatol. 2012;30(3):297–300. PubMed
Klang V, Schwarz JC, Lenobel B, Nadj M, Auböck J, Wolzt M, et al. In vitro vs. in vivo tape stripping: validation of the porcine ear model and penetration assessment of novel sucrose stearate emulsions. Eur J Pharm Biopharm. 2012;80(3):604–14. PubMed
Lademann J, Jacobi U, Surber C, Weigmann HJ, Fluhr JW. The tape stripping procedure – evaluation of some critical parameters. Eur J Pharm Biopharm. 2009;72(2):317–23. PubMed
Tsai JC, Sheu HM, Hung PL, Cheng CL. Effect of barrier disruption by acetone treatment on the permeability of compounds with various lipophilicities: implications for the permeability of compromised skin. J Pharm Sci. 2001;90(9):1242–54. PubMed
Löffler H, Dreher F, Maibach HI. Stratum corneum adhesive tape stripping: influence of anatomical site, application pressure, duration and removal. Br J Dermatol. 2004;151(4):746–52. PubMed
Rissmann R, Oudshoorn MHM, Hennink WE, Ponec M, Bouwstra JA. Skin barrier disruption by acetone: observations in a hairless mouse skin model. Arch Dermatol Res. 2009;301(8):609–13. PubMed PMC
Fluhr JW, Feingold KR, Elias PM. Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models. Exp Dermatol. 2006;15(7):483–92. PubMed
Siewert M, Dressman J, Brown CK, Shah VP, Aiache J-M, Aoyagi N, et al. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech. 2003;4(1):43–52. PMC
Chilcott RP, Dalton CH, Emmanuel AJ, Allen CE, Bradley ST. Transepidermal water loss does not correlate with skin barrier function in vitro. J Invest Dermatol. 2002;118(5):871–5. PubMed
Levin J, Maibach H. The correlation between transepidermal water loss and percutaneous absorption: an overview. J Control Release. 2005;103(2):291–9. PubMed
Čuříková BA, Procházková K, Filková B, Diblíková P, Svoboda J, Kováčik A, et al. Simplified stratum corneum model membranes for studying the effects of permeation enhancers. Int J Pharm. 2017;534(1):287–96. PubMed
Kopecna M, Machacek M, Prchalova E, Stepanek P, Drasar P, Kotora M, et al. Dodecyl amino glucoside enhances transdermal and topical drug delivery via reversible interaction with skin barrier lipids. Pharm Res. 2017;34(3):640–53. PubMed
Lasch J, Weissig V, Brandl MJLapa. Preparation of liposomes. 2003;2:24-5.
Sochorová M, Staňková K, Pullmannová P, Kováčik A, Zbytovská J, Vávrová K. Permeability barrier and microstructure of skin lipid membrane models of impaired glucosylceramide processing. Sci Rep. 2017;7(1).
Gysler A, Kleuser B, Sippl W, Lange K, Korting HC, Höltje H-D, et al. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Pharm Res. 1999;16(9):1386–91. PubMed
Carrer V, Guzmán B, Martí M, Alonso C, Coderch L. Lanolin-based synthetic membranes as percutaneous absorption models for transdermal drug delivery. Pharmaceutics. 2018;10(3):73. PMC
Kopečná M, Macháček M, Prchalová E, Štěpánek P, Drašar P, Kotora M, et al. Galactosyl pentadecene reversibly enhances transdermal and topical drug delivery. Pharm Res. 2017;34(10):2097–108. PubMed
Buraczewska I, Berne B, Lindberg M, Törmä H, Lodén MJBJoD. Changes in skin barrier function following long‐term treatment with moisturizers, a randomized controlled trial. 2007;156(3):492–8.
Yang L, Mao-QlAng M, Taljebini M, Elias PM, Feingold KR. Topical stratum corneum lipids accelerate barrier repair after tape stripping, solvent treatment and some but not all types of detergent treatment. Br J Dermatol. 1995;133(5):679–85. PubMed
Visscher MO, Hoath SB, Conroy E, Wickett RR. Effect of semipermeable membranes on skin barrier repair following tape stripping. Arch Dermatol Res. 2001;293(10):491–9. PubMed
Hathout RM, Mansour S, Mortada ND, Geneidi AS, Guy RH. Uptake of microemulsion components into the stratum corneum and their molecular effects on skin barrier function. Mol Pharm. 2010;7(4):1266–73. PubMed
Yu G, Zhang G, Flach C, Mendelsohn R. Vibrational spectroscopy and microscopic imaging: novel approaches for comparing barrier physical properties in native and human skin equivalents. J Biomed Opt. 2012;18(6):061207.
Clancy MJ, Corish J, Corrigan OI. A comparison of the effects of electrical current and penetration enhancers on the properties of human skin using spectroscopie (FTIR) and calorimetric (DSC) methods. Int J Pharm. 1994;105(1):47–56.
Jacobi U, Weigmann HJ, Ulrich J, Sterry W, Lademann J. Estimation of the relative stratum corneum amount removed by tape stripping. Skin Res Technol. 2005;11(2):91–6. PubMed
Kalia YN, Alberti I, Sekkat N, Curdy C, Naik A, Guy RH. Normalization of stratum corneum barrier function and transepidermal water loss in vivo. Pharm Res. 2000;17(9):1148–50. PubMed
Gao Y, Wang X, Chen S, Li S, Liu X. Acute skin barrier disruption with repeated tape stripping: an in vivo model for damage skin barrier. Skin Res Technol. 2013;19(2):162–8. PubMed
Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(1):911–7. PubMed
Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. 1998.
Mitragotri S. Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J Control Rel. 2003;86(1):69–92.
Johnson ME, Berk DA, Blankschtein D, Golan DE, Jain RK, Langer RS. Lateral diffusion of small compounds in human stratum corneum and model lipid bilayer systems. Biophys J. 1996;71(5):2656–68. PubMed PMC
Jacobi U, Taube H, Schäfer UF, Sterry W, Lademann J. Comparison of four different in vitro systems to study the reservoir capacity of the stratum corneum. J Control Release. 2005;103(1):61–71. PubMed
Rougier A, Rallis M, Krien P, Lotte C. In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning. Arch Dermatol Res. 1990;282(8):498–505. PubMed
Fartasch M. Ultrastructure of the epidermal barrier after irritation. Microsc Res Tech. 1997;37(3):193–9. PubMed
Patil S, Singh P, Sarasour K, Maibach H. Quantification of sodium lauryl sulfate penetration into the skin and underlying tissues after topical application—pharmacological and toxicological implications. J Pharm Sci. 1995;84(10):1240–4. PubMed
di Nardo A, Sugino K, Wertz P, Ademola J, Maibach HI. Sodium lauryl sulfate (SLS) induced irritant contact dermatitis: a correlation study between ceramides and in vivo parameters of irritation. Contact Dermatitis. 1996;35(2):86–91. PubMed
Lévêque JL, de Rigal J, Saint-Léger D, Billy D. How does sodium lauryl sulfate alter the skin barrier function in man? A multiparametric approach. Skin Pharmacol Physiol. 1993;6(2):111–5.
Froebe CL, Simion FA, Rhein LD, Cagan RH, Kligman A. Stratum corneum lipid removal by surfactants: relation to in vivo irritation. Dermatology. 1990;181(4):277–83.
Čuříková-Kindlová BA, Diat O, Štěpánek F, Vávrová K, Zbytovská J. Probing the interactions among sphingosine and phytosphingosine ceramides with non- and alpha-hydroxylated acyl chains in skin lipid model membranes. Int J Pharm. 2019;563:384–94. PubMed
Lodén M, Bárány E. Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin. Acta Derm-Venereol. 2000;80(6):412–5. PubMed
Hatziantoniou S, Rallis M, Demetzos C, Papaioannou GT. Pharmacological activity of natural lipids on a skin barrier disruption model. Pharmacol Res. 2000;42(1):55–9. PubMed
De Paepe K, Roseeuw D, Rogiers V. Repair of acetone- and sodium lauryl sulphate-damaged human skin barrier function using topically applied emulsions containing barrier lipids. J Eur Acad Dermatol Venereol. 2002;16(6):587–94. PubMed
Man M-Q, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol. 1993;129(6):728–38. PubMed
Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 2003;258(1):141–51. PubMed
de Pera M, Coderch L, Fonollosa J, de la Maza A, Parra JL. Effect of internal wool lipid liposomes on skin repair. Skin Pharmacol Physiol. 2000;13(3–4):188–95.
Kucharekova M, Schalkwijk J, Van De Kerkhof PCM, Van De Valk PGM. Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction. Contact Dermatitis. 2002;46(6):331–8. PubMed
Lynde CW, Andriessen A. A cohort study on a ceramide-containing cleanser and moisturizer used for atopic dermatitis. Cutis. 2014;93(4):207–13. PubMed
Sahle FF, Gebre-Mariam T, Dobner B, Wohlrab J, Neubert RHH. Skin diseases associated with the depletion of stratum corneum lipids and stratum corneum lipid substitution therapy. Skin Pharmacol Physiol. 2015;28(1):42–55. PubMed
Zhang Q, Flach CR, Mendelsohn R, Mao G, Pappas A, Mack MC, et al. Topically applied ceramide accumulates in skin glyphs. Clin Cosmet Investig Dermatol. 2015;8:329–37. PubMed PMC
Sjövall P, Skedung L, Gregoire S, Biganska O, Clément F, Luengo GS. Imaging the distribution of skin lipids and topically applied compounds in human skin using mass spectrometry. Sci Rep. 2018;8(1):16683. PubMed PMC
Imokawa G, Akasaki S, Minematsu Y, Kawai M. Importance of intercellular lipids in water-retention properties of the stratum corneum: induction and recovery study of surfactant dry skin. Arch Dermatol Res. 1989;281(1):45–51. PubMed
Schoenwald RD, Stewart P. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. J Pharm Sci. 1980;69(4):391–4. PubMed
Lippacher A, Müller RH, Mäder K. Liquid and semisolid SLN PubMed
du Plessis J, Ramachandran C, Weiner N, Müller DG. The influence of particle size of liposomes on the deposition of drug into skin. Int J Pharm. 1994;103(3):277–82.
Sakuyama S, Hirabayashi C, Hasegawa J-I, Yoshida S. Analysis of human face skin surface molecules in situ by Fourier-transform infrared spectroscopy. Skin Res Technol. 2010;16(2):151–60. PubMed
Brancaleon L, Bamberg MP, Sakamaki T, Kollias N. Attenuated total reflection–Fourier transform infrared spectroscopy as a possible method to investigate biophysical parameters of stratum corneum in vivo. J Invest Dermatol. 2001;116(3):380–6. PubMed
Boncheva M, Damien F, Normand V. Molecular organization of the lipid matrix in intact Stratum corneum using ATR-FTIR spectroscopy. Biochim Biophys Acta (BBA) - Biomembr. 2008;1778(5):1344–55.
Bernard G, Auger M, Soucy J, Pouliot R. Physical characterization of the stratum corneum of an in vitro psoriatic skin model by ATR-FTIR and Raman spectroscopies. Biochim Biophys Acta (BBA) - Gen Subj. 2007;1770(9):1317–23.
He W, Guo X, Xiao L, Feng M. Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers. Int J Pharm. 2009;382(1):234–43. PubMed
Schwarz JC, Klang V, Hoppel M, Mahrhauser D, Valenta C. Natural microemulsions: formulation design and skin interaction. Eur J Pharm Biopharm. 2012;81(3):557–62. PubMed
Pilgram GSK, Vissers DCJ, van der Meulen H, Koerten HK, Pavel S, Lavrijsen SPM, et al. Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol. 2001;117(3):710–7. PubMed
Gorcea M, Hadgraft J, Moore DJ, Lane ME. In vivo barrier challenge and initial recovery in human facial skin. Skin Res Technol. 2013;19(1):e375–82. PubMed
Ramsing DW, Agner T. Effect of glove occlusion on human skin (II). Contact Dermatitis. 1996;34(4):258–62. PubMed
Zhai H, Maibach HI. Occlusion vs. skin barrier function. Skin Res Technol. 2002;8(1):1–6. PubMed
Iikura H, Uchida K, Ogawa-Fuse C, Bito K, Naitou S, Hosokawa M, et al. Effects of temperature and humidity on the skin permeation of hydrophilic and hydrophobic drugs. AAPS PharmSciTech. 2019;20(7):264. PubMed